Pegasys subcutaneous injection 180 μg, manufactured by Chugai Pharmaceutical, contains Peginterferon alpha-2a (genetical recombination). This injectable drug (YJ code: 6399419A2029) is supplied as 180μg in 1mL per bottle and is used to treat chronic hepatitis B and C by helping the immune system fight the viruses.
Pegasys subcutaneous injection 180 μg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →